Cumberland Pharmaceuticals (CPIX) is a small cap pharmaceutical company that already has three drugs on the market. One thing that makes it stand out from many other companies with its market cap is the fact that Cumberland is already profitable. Cumberland's extension of the distribution agreement with Cardinal Health is important to helping to continue to drive revenue growth out of Cumberland's current pipeline. Cumberland's three drugs have the potential to grow even more over the long term, and Cumberland is attempting to build a pipeline that will allow for even more long term oriented growth. Cumberland appears to be a solid value for long term oriented shareholders.
Cumberland's biggest drug by far is its drug...
Only subscribers can access this article, which is part of the PRO research library covering 3,570 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: